Showing 8,401 - 8,420 results of 15,870 for search '(( six ((we decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.97s Refine Results
  1. 8401

    Table 1_Global, regional, and national burden of atrial fibrillation/flutter attributable to metabolic, behavioral, and environmental risk factors, 1990–2021: a longitudinal observ... by Zhen Wei (203204)

    Published 2025
    “…</p>Results<p>Over the past 32 years, high body mass index has been the primary contributor to the rising AF/AFL burden, with AAPCs of ASMR and ASDR at 1.66 (95% CI: 1.63–1.68) and 1.68 (95% CI: 1.67–1.70), respectively. …”
  2. 8402

    Top-ranked motifs associated with aging effects in mouse tail skin (CB6F1 strain): Overlap with top-ranked human motifs but dissimilar associations with aging. by William R. Swindell (175427)

    Published 2012
    “…For each motif (left margin), gene sets associated with a varying number of motif occurrences (in the region 2000 BP upstream/200 BP downstream of the transcription start site) were derived. For any one motif, gene sets with fewer motif occurrences were always larger than those sets containing genes with more motif occurrences (see legend in right margin). …”
  3. 8403

    DataSheet1_Synthesis and characterization of 3D-zeolite–modified TiO2-based photocatalyst with synergistic effect for elimination of organic pollutant in wastewater treatment.docx... by Na Liu (102929)

    Published 2022
    “…The results showed that Z-PAgT-5 performed the highest photodegradation efficiency, and its degradation rate constant (k<sub>app</sub>) (0.188 min<sup>−1</sup>) is much higher than that of Z-PAgT-0 (0.132 min<sup>−1</sup>), Z-PAgT-10 (0.050 min<sup>−1</sup>), Z-PAgT-25 (0.037 min<sup>−1</sup>), and pure zeolite (0.003 min<sup>−1</sup>). …”
  4. 8404

    Table_1_A Common 3′UTR Variant of the PHOX2B Gene Is Associated With Infant Life-Threatening and Sudden Death Events in the Italian Population.xlsx by Tiziana Bachetti (361249)

    Published 2021
    “…Here, we report that the c<sup>*</sup>161G>A (rs114290493) SNP of the 3′UTR PHOX2B (i) became overrepresented in the two sets of patients compared to population matched healthy controls, and (ii) associated with decreased PHOX2B gene expression, likely mediated by miR-204, a microRNA already known to bind the 3′UTR of the PHOX2B gene. …”
  5. 8405

    DataSheet_1_Epidemiology and risk stratification of low-grade gliomas in the United States, 2004-2019: A competing-risk regression model for survival analysis.docx by Junguo Cao (14693755)

    Published 2023
    “…The incidence rate of mixed gliomas was stable from 2004 to 2013 and decreased dramatically to nearly zero until 2019. The risk of death increased 1.99 times for every 20-year increase in patient age, and 60 years is a predictive cut-off age for risk stratification of LGGs. …”
  6. 8406

    DataSheet1_Achilles tendon compliance influences tendon loading more than Achilles tendon twist in Achilles tendinopathy: a musculoskeletal modeling approach.docx by Ine Mylle (13006902)

    Published 2024
    “…Results indicated that tendon compliance had a larger effect than tendon twist on triceps surae muscle forces. …”
  7. 8407
  8. 8408

    Presentation_1_A Common 3′UTR Variant of the PHOX2B Gene Is Associated With Infant Life-Threatening and Sudden Death Events in the Italian Population.PPT by Tiziana Bachetti (361249)

    Published 2021
    “…Here, we report that the c<sup>*</sup>161G>A (rs114290493) SNP of the 3′UTR PHOX2B (i) became overrepresented in the two sets of patients compared to population matched healthy controls, and (ii) associated with decreased PHOX2B gene expression, likely mediated by miR-204, a microRNA already known to bind the 3′UTR of the PHOX2B gene. …”
  9. 8409

    Data_Sheet_1_Reduced Expression of Prion Protein With Increased Interferon-β Fail to Limit Creutzfeldt-Jakob Disease Agent Replication in Differentiating Neuronal Cells.docx by Gerard Aguilar (12104756)

    Published 2022
    “…High titers of CJD agent also induced dramatic decreases in host PrP, a protein needed for productive agent replication. …”
  10. 8410

    DataSheet_1_Interactions Between Adiponectin-Pathway Polymorphisms and Obesity on Postmenopausal Breast Cancer Risk Among African American Women: The WHI SHARe Study.docx by Gina E. Nam (11163786)

    Published 2021
    “…The joint effect of BMI ≥ 30 kg/m<sup>2</sup> and the TC genotype of OR8S1 rs11168618 was larger than the sum of the independent effects on breast cancer risk.…”
  11. 8411

    Preliminary efficacy of eye movement desensitization and reprocessing for children aged 1.5–8 years with PTSD: a multiple baseline experimental design (<i>N</i> = 19) by Carlijn de Roos (8061239)

    Published 2025
    “…</p> <p><b>Conclusions:</b> The findings provide preliminary evidence of the safety, feasibility, and efficacy of six sessions of EMDR therapy for reducing paediatric PTSD and comorbidity in young children aged 1.5–8 years and, at the same time, decreasing parenting stress. …”
  12. 8412

    Data_Dheet_1_Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium.zip by Simon Farkas (8848784)

    Published 2020
    “…We present a novel serum-free differentiation protocol that exploits the synergy of multiple powerful differentiation effectors. …”
  13. 8413

    Data_Dheet_1_Endothelial Progenitor Cells Produced From Human Pluripotent Stem Cells by a Synergistic Combination of Cytokines, Small Compounds, and Serum-Free Medium.zip by Simon Farkas (8848784)

    Published 2020
    “…We present a novel serum-free differentiation protocol that exploits the synergy of multiple powerful differentiation effectors. …”
  14. 8414

    Data_Sheet_2_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  15. 8415

    Data_Sheet_1_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  16. 8416

    Data_Sheet_3_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  17. 8417

    Data_Sheet_4_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  18. 8418

    Data_Sheet_5_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  19. 8419
  20. 8420

    Table_1_Long-Term Outcomes of Bronchopulmonary Dysplasia Under Two Different Diagnostic Criteria: A Retrospective Cohort Study at a Chinese Tertiary Center.pdf by Ling Sun (301114)

    Published 2021
    “…The mean ± standard deviation gestational age and birth weight of the 417 eligible infants were 29.1 ± 1.4 weeks and 1186.6 ± 197.8 g, respectively. …”